Related Experiment Video
Updated: Feb 22, 2026

Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays
Published on: January 7, 2016
Growth Hormone Improves Cardiopulmonary Capacity and Body Composition in Children With Growth Hormone Deficiency
Donatella Capalbo1, Flavia Barbieri1, Nicola Improda1
1Department of Translational Medical Sciences, Pediatric Section, Federico II University of Naples, 80131 Naples, Italy.
Insights
Children with growth hormone deficiency (GHD) have impaired cardiac structure, body composition, and exercise capacity. Growth hormone (GH) therapy effectively restored these parameters in a 12-month study.
Area of Science:
- Pediatric Endocrinology
- Cardiology
- Exercise Physiology
Background:
- Growth hormone deficiency (GHD) in children may impact cardiovascular health and functional capacity.
- Limited data exists on cardiopulmonary function in pediatric GHD.
Purpose of the Study:
- To assess the effects of GHD and growth hormone (GH) therapy on cardiopulmonary function.
- To evaluate changes in cardiac structure and function.
- To analyze alterations in body composition in children and adolescents with GHD.
Main Methods:
- Prospective case-control study involving 21 children with GHD and 21 matched controls.
- Evaluations included cardiopulmonary exercise testing, echocardiography, and dual-energy x-ray absorptiometry.
- Measurements were taken before and after 12 months of GH therapy for the GHD group.
Main Results:
- Untreated GHD children exhibited reduced left ventricular mass, peak oxygen consumption, workload, and O2 pulse compared to controls.
- GHD patients had lower lean body mass and higher fat mass.
- GH therapy significantly improved cardiac structure, cardiopulmonary capacity, and body composition, with no changes in ventricular function.
Conclusions:
- Children with untreated GHD present with impaired cardiac structure, body composition, and cardiopulmonary capacity.
- Short-term GH replacement therapy can effectively restore these parameters in pediatric GHD patients.
Context:
Growth hormone deficiency (GHD) in children may be associated with early cardiovascular risk factors and alterations in left ventricular (LV) structure and function; data on cardiopulmonary functional capacity are lacking.
Objectives:
Aim of the study was to evaluate the effect of GHD and growth hormone (GH) therapy on cardiopulmonary functional capacity, left and right cardiac structure and function, and body composition in children and adolescents.
Design:
Prospective, case-control study.
Patients And Methods:
Twenty-one untrained GHD children (11.3 ± 0.8 years) underwent cardiopulmonary exercise testing, echocardiography and dual-energy x-ray absorptiometry, before and after 12 months of GH therapy. Twenty-one controls matched for sex, pubertal status, body mass index, and physical activity (PA) were evaluated at baseline and after 1 year.
Results:
At baseline, GHD patients showed reduced LV mass (LVM; 63.32 ± 7.80 vs 80.44 ± 26.29 g/m2, P = 0.006), peak oxygen consumption (VO2peak; 22.92 ± 4.80 vs 27.48 ± 6.71 mL/Kg/min, P = 0.02), peak workload (80.62 ± 29.32 vs 103.76 ± 36.20 W, P = 0.02), and O2 pulse (4.93 ± 1.30 vs 7.67 ± 2.93 mL/beat, P = 0.0003), compared with controls. GHD patients also exhibited lower lean body mass (LBM 65.36 ± 7.84% vs 76.13 ± 8.23%, P < 0.001), and higher fat mass (FM 30.84 ± 7.92% vs 22.19 ± 8.18%, P = 0.001) than controls. GH therapy resulted in a significant increase of LVM (72.01 ± 15.88, P = 0.03), VO2peak (26.80 ± 4.97; P = 0.01), peak workload (103.67 ± 32.24, P = 0.001), O2 pulse (6.64 ± 1.68, P = 0.0007), and LBM (75.36 ± 7.59%, P = 0.0001), with a reduction in FM (22.62 ± 7.73%, P = 0.001). No difference was found in either left or right ventricular function.
Conclusion:
Our results suggest that cardiac structure, body composition and cardiopulmonary functional capacity are impaired in children with untreated GHD and can be restored after short-term GH replacement therapy.
More Related Videos
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
05:38Generation and Expansion of Human Cardiomyocytes from Patient Peripheral Blood Mononuclear Cells
Published on: February 12, 2021
Related Concept Videos
Nature and Nurture
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Exercise and Cardiac Output
Sustained exercise increases the muscles' oxygen demand, which can be...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...